We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Surgical Innovations Group Plc | LSE:SUN | London | Ordinary Share | GB0004016704 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.50 | 0.40 | 0.60 | 0.50 | 0.50 | 0.50 | 1,596,354 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Surgical,med Instr,apparatus | 11.34M | 264k | 0.0003 | 16.67 | 4.66M |
TIDMSUN
RNS Number : 0932J
Surgical Innovations Group PLC
03 December 2018
Surgical Innovations Group plc
("Surgical Innovations" or "the "Company")
Appointment of Nominated Adviser and Broker
Surgical Innovations (AIM: SUN), the designer and manufacturer of innovative technology for minimally invasive surgery, announces the appointment of Nplus1 Singer Advisory LLP ("N+1 Singer") as Nominated Adviser and sole Broker to the Company with immediate effect.
For further information contact:
Surgical Innovations Group Plc www.sigroupplc.com Nigel Rogers, Executive Chairman Tel: +44 (0)113 230 7597 ---------------------------------------------- Melanie Ross, COO and CFO ---------------------------------------------- Walbrook PR (Financial PR & Investor Tel: +44 (0)20 7933 8780 or si@walbrookpr.com Relations) ---------------------------------------------- Paul McManus Mob: +44 (0)7980 541 893 ---------------------------------------------- Lianne Cawthorne Mob: +44 (0)7584 391 303 ---------------------------------------------- N+1 Singer - Nominated Adviser and Broker +44 (0)20 7496 3000 ---------------------------------------------- Richard Lindley ---------------------------------------------- Rachel Hayes ----------------------------------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
APPFDIFDSFASESF
(END) Dow Jones Newswires
December 03, 2018 02:01 ET (07:01 GMT)
1 Year Surgical Innovations Chart |
1 Month Surgical Innovations Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions